Safety and efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine antiretroviral therapy between HIV-infected patients with baseline CD4 <50 versus CD4 ≥ 50 cells/mm3.

Autor:	Manosuthi, Weerawat1 drweerawat@hotmail.com, Chimsuntorn, Sukanya1 drskychim@hotmail.com, Likanonsakul, Sirirat1 dimvbi@moph2.moph.go.th, Sungkanuparph, Somnuek2 rasuy@mahidol.ac.th
Zdroj:	AIDS Research & Therapy. 2007, Vol. 4, p1-8. 8p. 4 Charts, 2 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu